Characterization of a heparin binding site on the heavy chain of factor XI

被引:57
作者
Zhao, MM
Abdel-Razek, T
Sun, MF
Gailani, D
机构
[1] Vanderbilt Univ, Div Hematol Oncol, Dept Pathol, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Dept Med, Nashville, TN 37232 USA
关键词
D O I
10.1074/jbc.273.47.31153
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The glycosaminoglycan heparin enhances several reactions involving coagulation factor XI (FXI) including activation of FXI by factor XIIa, thrombin, and autoactivation; and inactivation of activated FXI (FXIa) by serine protease inhibitors. We examined the effect of heparin on inhibition of FXIa by the inhibitors C1-inhibitor (C1-INH) and antithrombin LII (ATIII), Second order rate constants for inhibition in the absence of heparin were 1.57 x 10(3) and 0.91 x 10(3) M-1 s(-1) for C1-INH and ATIII, respectively. Therapeutic heparin concentrations (0.1-1.0 units/ml) enhanced inhibition by ATIII 20-55-fold compared with 0.1-7.0-fold for C1-INH. For both inhibitors, the effect of heparin over a wide range of concentrations (10(-1) to 10(5) units/ml) produced bell-shaped curves, demonstrating that inhibition occurs by a template mechanism requiring both inhibitor and protease to bind to heparin, This implies that FXI/XIa contains structural elements that interact with heparin, Human FXI contains a sequence of amino acids (R-250-I-K-K-S-K) in the apple 3 domain of the heavy chain that binds heparin (Ho, D., Badellino, K., Baglia, F., and Walsh, P. (1998) J. Biol. Chem. 273, 16382-16390), To determine the importance of this sequence to heparin-mediated reactions, recombinant FXI molecules with alanine substitutions for basic amino acids were expressed in 293 fibroblasts, and tested in heparin-dependent assays. Inhibition of FXIa by ATIII in the presence of heparin was decreased 4-fold by alanine substitution at Lys(253) (A253), with smaller effects noted for mutants A255 and A252, FXI undergoes autoactivation to FXIa in the presence of heparin, The rate of autoactivation was decreased substantially for A253 with modest decreases for A255 and A252, Substituting all four charged residues in the sequence resulted in a profound decrease in autoactivation, significantly greater than for any single substitution. Relative affinity for heparin was tested by determining the concentration of NaCl required to elute FXIa from heparin-Sepharose. Wild type FXIa eluted from the column at 320 mM NaCl, whereas FXIa with multiple substitutions (A252-254 or A250-255) eluted at 230 mM NaCl, AU proteins with single substitutions in charged amino acids eluted at intermediate NaCl concentrations. The data indicate that FXI/XIa must bind to heparin for optimal inhibition by ATIII and for autoactivation. Lys(253) is the most important amino acid involved in binding, and Lys(255) and Lys(252) also have roles in interactions with heparin.
引用
收藏
页码:31153 / 31159
页数:7
相关论文
共 46 条
[1]   IDENTIFICATION AND CHARACTERIZATION OF A BINDING-SITE FOR PLATELETS IN THE APPLE-3 DOMAIN OF COAGULATION-FACTOR-XI [J].
BAGLIA, FA ;
JAMESON, BA ;
WALSH, PN .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (12) :6734-6740
[2]  
BEELER DL, 1986, BLOOD, V67, P1488
[3]  
BOUMA BN, 1977, J BIOL CHEM, V252, P6432
[4]   MOLECULAR MODELING OF PROTEIN-GLYCOSAMINOGLYCAN INTERACTIONS [J].
CARDIN, AD ;
WEINTRAUB, HJR .
ARTERIOSCLEROSIS, 1989, 9 (01) :21-32
[5]  
CHIU HM, 1977, BLOOD, V49, P171
[6]   STRUCTURE-ACTIVITY RELATIONSHIP IN HEPARIN - A SYNTHETIC PENTASACCHARIDE WITH HIGH-AFFINITY FOR ANTI-THROMBIN-III AND ELICITING HIGH ANTI-FACTOR-XA ACTIVITY [J].
CHOAY, J ;
PETITOU, M ;
LORMEAU, JC ;
SINAY, P ;
CASU, B ;
GATTI, G .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1983, 116 (02) :492-499
[7]   ACTIVATION OF HUMAN FACTOR-9 (CHRISTMAS-FACTOR) [J].
DISCIPIO, RG ;
KURACHI, K ;
DAVIE, EW .
JOURNAL OF CLINICAL INVESTIGATION, 1978, 61 (06) :1528-1538
[8]   HEPARIN BINDING-SITE, CONFORMATIONAL CHANGE, AND ACTIVATION OF ANTITHROMBIN [J].
EVANS, DL ;
MARSHALL, CJ ;
CHRISTEY, PB ;
CARRELL, RW .
BIOCHEMISTRY, 1992, 31 (50) :12629-12642
[9]  
FORBES CD, 1970, J LAB CLIN MED, V76, P809
[10]   AMINO-ACID-SEQUENCE OF HUMAN FACTOR-XI, A BLOOD-COAGULATION FACTOR WITH 4 TANDEM REPEATS THAT ARE HIGHLY HOMOLOGOUS WITH PLASMA PREKALLIKREIN [J].
FUJIKAWA, K ;
CHUNG, DW ;
HENDRICKSON, LE ;
DAVIE, EW .
BIOCHEMISTRY, 1986, 25 (09) :2417-2424